Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Village Health Partners
Location: 5425 W Spring Creek Pkwy #200, Plano, TX
Lead Doctor: Dr. Madhavi Ampajwala, MD

Background

Approximately 85% of people with Type 2 Diabetes are obese or overweight. Excess weight can make treatment of diabetes very difficult.

This research study is investigating whether certain combinations of FDA-approved diabetes medications can lead to both reduced blood sugar levels and weight loss.

Men and women who have Type 2 Diabetes and are currently taking metformin (e.g. Glucophage, Glumetza, Glucophage XR, Fortamet) or Janumet with, or without, additional diabetic medications.  Participants are required to attend about 9 study visits at the research site over 5 – 6 months. Participants will be paid $450 for attending site visits.

Benefits of Participation

• Your diabetes symptoms may improve.
• You may experience some weight loss.
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 18 – 65 years old
• Have Type 2 Diabetes, and struggle to control it
• Are currently taking metformin (e.g. Glucophage, Glumetza, Glucophage XR, Fortamet) or Janumet with, or without, additional diabetic medications.
• Able to attend 9 study visits at the research site over 5 – 6 months